Why Is Clover Wellness (CLOV) Stock Up Today? Director Chelsea Clinton purchased 100,000 shares of CLOV stock 

Now, shareholders of Clover Health and wellness (NASDAQ: CLOV) are smiling ear to ear. Although clov stock price today remains down more than 25% year-to-date (YTD), shares of the firm are up over 20% today.

Why precisely is Clover Health trading greater now?

Over the weekend, it was reported that Clover director Chelsea Clinton had actually lately bought shares of CLOV stock. The transaction, which happened on March 3, saw Clinton acquire 100,000 shares for a typical price of $2.52 per share. In total amount, Clinton’s current transaction totaled up to $252,530, according to a Kind 4 submitted to the U.S. Stocks as well as Exchange Payment (SEC).

Why Is CLOV Stock Up Today?
Right now, CLOV stock is up in action to Clinton’s acquisition, which financiers are considering as a positive signal. Oftentimes, director trading task similar to this is essential to track because insiders often have a far better view of a company’s long-term growth potential than retail capitalists.

So, keeping that in mind, are various other experts of Clover bullish on the firm? In the past twelve month, experts have purchased 2.2 million shares and marketed 22.9 million shares. That’s an internet of 20.6 million shares sold. This mass expert selling appears to associate with CLOV stock’s decline of greater than 60% over the past one year.

Still, with Clinton’s recent acquisition, investors are questioning that else is wagering big on Clover Health and wellness. Let’s jump right in.

That Else Is Betting Big on Clover Health?
As of the fourth quarter, 160 institutional investors own shares of CLOV stock. That marks a quarter-0ver-quarter (QOQ) rise of 8.8%. During the period, the overall quantity of shares held by institutional capitalists likewise raised from 105.7 million to 129.8 million, up nearly 23% QOQ. Let’s take a look on top five institutional shareholders.

Lead has 25.9 million shares or 7.65% ownership. The firm purchased 8.8 million shares throughout Q4.
Greenoaks Funding Partners has 24.8 million shares or 7.34% ownership. The company sold 24.8 million shares throughout Q4.
Baillie Gifford has 7.8 million shares or 2.3% possession. The company acquired 2.6 million shares throughout Q4.
Two Sigma Investments has 6.6 million shares or 1.95% ownership. The company purchased all 6.6 million shares during Q4.
PNC Financial Services (NYSE: PNC) possesses 6.4 million shares or 1.88% possession. The firm sold 249,850 shares throughout Q4.
Out of the leading 5 shareholders, 3 funds reduced their positions and two funds raised their placements. Greenoaks Resources Allies had the most remarkable transaction, as the fund marketed concerning 50% of its existing placement throughout Q4. Two Sigma’s 6.6 million share purchase was also noteworthy, as the procurement placed it amongst the leading 5 investors.